Editor’s Note: This article was originally published in 2018 and is preserved for historical interest. Some recommendations, regulations, and scientific evidence have changed since it was written. It reflects the research and perspectives available at that time.
A small study involving five patients with neuropathic pain appeared in the Clinical Journal of Pain (2010; 26(2): 168-72). The patients were given a high dose of omega-3 fatty acids (between 2400 and 7200 mg/day of EPA-DHA) over a period of 19 months. All experienced reduction in pain. The authors believe that this indicates omega-3 fatty acids may be beneficial for pain management and more studies are warranted.
